178 related articles for article (PubMed ID: 24977159)
1. Epigenetic alterations of chromosome 3 revealed by NotI-microarrays in clear cell renal cell carcinoma.
Dmitriev AA; Rudenko EE; Kudryavtseva AV; Krasnov GS; Gordiyuk VV; Melnikova NV; Stakhovsky EO; Kononenko OA; Pavlova LS; Kondratieva TT; Alekseev BY; Braga EA; Senchenko VN; Kashuba VI
Biomed Res Int; 2014; 2014():735292. PubMed ID: 24977159
[TBL] [Abstract][Full Text] [Related]
2. Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays.
Dmitriev AA; Kashuba VI; Haraldson K; Senchenko VN; Pavlova TV; Kudryavtseva AV; Anedchenko EA; Krasnov GS; Pronina IV; Loginov VI; Kondratieva TT; Kazubskaya TP; Braga EA; Yenamandra SP; Ignatjev I; Ernberg I; Klein G; Lerman MI; Zabarovsky ER
Epigenetics; 2012 May; 7(5):502-13. PubMed ID: 22491060
[TBL] [Abstract][Full Text] [Related]
3. Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer.
Senchenko VN; Kisseljova NP; Ivanova TA; Dmitriev AA; Krasnov GS; Kudryavtseva AV; Panasenko GV; Tsitrin EB; Lerman MI; Kisseljov FL; Kashuba VI; Zabarovsky ER
Epigenetics; 2013 Apr; 8(4):409-20. PubMed ID: 23478628
[TBL] [Abstract][Full Text] [Related]
4. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
5. NotI microarrays: novel epigenetic markers for early detection and prognosis of high grade serous ovarian cancer.
Kashuba V; Dmitriev AA; Krasnov GS; Pavlova T; Ignatjev I; Gordiyuk VV; Gerashchenko AV; Braga EA; Yenamandra SP; Lerman M; Senchenko VN; Zabarovsky E
Int J Mol Sci; 2012 Oct; 13(10):13352-77. PubMed ID: 23202957
[TBL] [Abstract][Full Text] [Related]
6. [Technology of analysis of epigenetic and structural changes of epithelial tumors genome with NotI-microarrays by the example of human chromosome].
Pavlova TV; Kashuba VI; Muravenko OV; Yenamandra SP; Ivanova TA; Zabarovskaia VI; Rakhmanaliev ER; Petrenko LA; Pronina IV; Loginov VI; Iurkevich OIu; Kiselev LL; Zelenin AV; Zabarovskiĭ ER
Mol Biol (Mosk); 2009; 43(2):339-47. PubMed ID: 19425501
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
[TBL] [Abstract][Full Text] [Related]
8. Genetic and epigenetic changes of NKIRAS1 gene in human renal cell carcinomas.
Gerashchenko GV; Bogatyrova OO; Rudenko EE; Kondratov AG; Gordiyuk VV; Zgonnyk YM; Vozianov OF; Pavlova TV; Zabarovsky ER; Rynditch AV; Kashuba VI
Exp Oncol; 2010 Jul; 32(2):71-5. PubMed ID: 20693965
[TBL] [Abstract][Full Text] [Related]
9. NotI subtraction and NotI-specific microarrays to detect copy number and methylation changes in whole genomes.
Li J; Protopopov A; Wang F; Senchenko V; Petushkov V; Vorontsova O; Petrenko L; Zabarovska V; Muravenko O; Braga E; Kisselev L; Lerman MI; Kashuba V; Klein G; Ernberg I; Wahlestedt C; Zabarovsky ER
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10724-9. PubMed ID: 12149436
[TBL] [Abstract][Full Text] [Related]
10. Deletion of chromosome 3p14.2-p25 involving the VHL and FHIT genes in conventional renal cell carcinoma.
Sükösd F; Kuroda N; Beothe T; Kaur AP; Kovacs G
Cancer Res; 2003 Jan; 63(2):455-7. PubMed ID: 12543802
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
12. Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease.
Gattolliat CH; Couvé S; Meurice G; Oréar C; Droin N; Chiquet M; Ferlicot S; Verkarre V; Vasiliu V; Molinié V; Méjean A; Dessen P; Giraud S; Bressac-De-Paillerets B; Gardie B; Tean Teh B; Richard S; Gad S
Int J Oncol; 2018 Oct; 53(4):1455-1468. PubMed ID: 30066860
[TBL] [Abstract][Full Text] [Related]
13. LRRC3B gene is frequently epigenetically inactivated in several epithelial malignancies and inhibits cell growth and replication.
Haraldson K; Kashuba VI; Dmitriev AA; Senchenko VN; Kudryavtseva AV; Pavlova TV; Braga EA; Pronina IV; Kondratov AG; Rynditch AV; Lerman MI; Zabarovsky ER
Biochimie; 2012 May; 94(5):1151-7. PubMed ID: 22321817
[TBL] [Abstract][Full Text] [Related]
14. The genetic locus NRC-1 within chromosome 3p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment, and VHL mutation.
Lovell M; Lott ST; Wong P; El-Naggar A; Tucker S; Killary AM
Cancer Res; 1999 May; 59(9):2182-9. PubMed ID: 10232606
[TBL] [Abstract][Full Text] [Related]
15. Genetic and epigenetic alterations during renal carcinogenesis.
Arai E; Kanai Y
Int J Clin Exp Pathol; 2010 Dec; 4(1):58-73. PubMed ID: 21228928
[TBL] [Abstract][Full Text] [Related]
16. Epigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma.
Mehdi A; Riazalhosseini Y
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28812986
[TBL] [Abstract][Full Text] [Related]
17. Frequent epigenetic suppression of tumor suppressor gene glutathione peroxidase 3 by promoter hypermethylation and its clinical implication in clear cell renal cell carcinoma.
Liu Q; Jin J; Ying J; Sun M; Cui Y; Zhang L; Xu B; Fan Y; Zhang Q
Int J Mol Sci; 2015 May; 16(5):10636-49. PubMed ID: 25970749
[TBL] [Abstract][Full Text] [Related]
18. An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies.
Protopopov A; Kashuba V; Zabarovska VI; Muravenko OV; Lerman MI; Klein G; Zabarovsky ER
Cancer Res; 2003 Jan; 63(2):404-12. PubMed ID: 12543795
[TBL] [Abstract][Full Text] [Related]
19. [Methylation in the Regulation of the Expression of Chromosome 3 and microRNA Genes in Clear-Cell Renal Cell Carcinomas].
Braga EA; Khodyrev DS; Loginov VI; Pronina IV; Senchenko VN; Dmitriev AA; Kubatiev AA; Kushlinskii NE
Genetika; 2015 Jun; 51(6):668-84. PubMed ID: 26310030
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
